益气化瘀方治疗非手术老年慢性硬膜下血肿临床观察

ISSN:2811-051X(P)

EISSN:2811-0781(O)

语言:中文

作者
张征达,张 弛,王永谦
文章摘要
目的:观察探讨益气化瘀方治疗老年创伤性慢性硬膜下血肿的临床疗效评估。方法:选取我院2017年1月至2020年12月的72例非手术老年慢性硬膜下血肿患者,按随机分配原则分为对照组和观察组,各36例。对照组患者行常规止血、营养支持等常规治疗,另服用阿托伐他汀;观察组在对照组的常规治疗基础上,采用服用益气化瘀方,7天为1个疗程,共8个疗程。观察两组患者的颅内血肿吸收情况。结果:两组患者进行各自治疗后在血肿吸收率上具有明显差异,观察组的血肿吸收率优于对照组,具有统计学意义(P<0.05)。观察组血肿吸收有效率88.89%,对照组总有效率58.83%。观察组总有效率明显高于对照组,有明显差异,具有统计学意义(P<0.05)。结论:益气化瘀方治疗非手术老年慢性硬膜下血肿有效率高,并能降低二次复发可能。
文章关键词
硬膜下血肿;益气化瘀法;中西医结合
参考文献
[1] 王忠诚.神经外科学[M].武汉:湖北科学技术出版社,1998:336-338. [2] Jiang R, Zhao S, Wang R, Feng H, Zhang J, Li X, Mao Y, Yuan X, Fei Z, Zhao Y, Yu X, Poon WS, Zhu X, Liu N, Kang D, Sun T, Jiao B, Liu X, Yu R, Zhang J, Gao G, Hao J, Su N, Yin G, Zhu X, Lu Y, Wei J, Hu J, Hu R, Li J, Wang D, Wei H, Tian Y, Lei P, Dong JF, Zhang J.Safety and Efficacy of Atorvastatin for Chronic Subdural Hematoma in Chinese Patients: A Randomized ClinicalTrial.JAMA Neurol. 2018 Nov 1;75(11):1338-1346. [3] 施杞.益气化瘀法治疗慢性硬脑膜下血肿12例[J].上海中医药杂志,1983,1:6-9. [4] 张征达.王永谦.益气活血法治疗老年慢性硬膜下血肿钻孔术后疗效观察[J].内蒙古中医药杂志,2016. [5] Virchow R. Das haematom der dura mater [J]. Verh PhysMed Ges Wurzburg, 1857, 7: 134-1342. [6] Drapkin AJ. Chronic subdural hematoma: pathophysiologicalbasis for treatment [J]. Br J Neurosurg, 1991, 5: 467-473. [7] Quintana LM. Chronic subdural hematoma after neurosurgicalprocedures [J]. World Neurosurg, 2013, 80(5): 482-483. [8] Chang CL, Sim JL, Delgardo MW, Ruan DT, Connolly ES Jr.Predicting Chronic Subdural Hematoma Resolution and Time to Resolution Following Surgical Evacuation[J].Front Neurol. 2020 Jul 14;11:677. [9] Holl DC, Volovici V, Dirven CMF, Peul WC, van Kooten F, Jellema K, van der Gaag NA, Miah IP, Kho KH, den Hertog HM, Lingsma HF, Dammers R; Dutch Chronic Subdural Hematoma Research Group (DSHR).Pathophysiology and Nonsurgical Treatment of Chronic Subdural Hematoma: From Past to Present to Future[J].World Neurosurg. 2018 Aug;116:402-411.e2. [10] 江同文.阿托伐他汀联合钻孔引流术治疗慢性硬膜下血肿的临床疗效及其对患者预后的影响[J].临床合理用药,2022,15(9):80-82. [11] 卓健伟,杨理申,朱洁等.阿托伐他汀对慢性硬膜下血肿患者术后MBI、CSS评分的影响[J].现代生物医学进展,2020,20(18):3582-3586. [12] Fan Y, Wang D, Rao C, Li Y, Rong H, Wang Z, Zhang J.Atorvastatin Combined with Low-Dose Dexamethasone Treatment Protects Endothelial Function Impaired by Chronic Subdural Hematoma via the Transcription Factor KLF-2.Drug Des Devel Ther. 2020 Aug 12;14:3291-3299. [13] 宋直昇,王拥军.施杞治疗慢性硬脑膜下血肿经验[J].中医杂志,2013,54(14):1189-1191. [14] 冯现永,张丽.黄芪桂枝五物汤联合曲克芦丁对脑梗死恢复期患者脑血流动力学及预后的影响[J].华夏医学.2020,33(6):170-173.
Full Text:
DOI